Home » Topics » BioWorld Science

BioWorld Science
RSS

Sorrento's STI-9167 neutralizes Omicron and Omicron (+R346k) variants of SARS-CoV-2

Jan. 24, 2022

Anti-ANXA1 antibody MDX-124 shows promise in preclinical models of pancreatic cancer

Jan. 24, 2022

HS6ST2 predicts survival in PDAC

Jan. 24, 2022

IM-1761065, a novel biguanide with promising activity in models of glioblastoma

Jan. 24, 2022

Oasmia advances its next-generation XR-18 drug delivery technology

Jan. 24, 2022

Engineered virus-like particles for in vivo delivery of gene editing proteins

Jan. 24, 2022

New approach integrates CAR-T cell immunotherapy with local activation of small-molecule prodrugs

Jan. 24, 2022

Inventisbio Shanghai discloses GTPase KRAS mutant inhibitors

Jan. 24, 2022

Shanghai Institute of Materia Medica identifies new S1PR1 agonists

Jan. 24, 2022

Immunophage Biomedical presents new CCR8 antagonists

Jan. 24, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...